Core Points - WORK Medical Technology Group LTD has received a notification from Nasdaq granting an additional 180-calendar-day period to regain compliance with the minimum bid price requirement [1][3] - The initial notice from Nasdaq indicated that WORK Medical's stock had failed to meet the minimum bid price requirement for 30 consecutive business days, leading to an initial compliance period that expired on October 6, 2025 [2] - To regain compliance, WORK Medical's stock must achieve a minimum closing bid price of $1.00 per share for at least 10 consecutive business days during the additional compliance period [4] Company Overview - WORK Medical Technology Group LTD, through its subsidiary, is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices [5] - The company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks, and has sold products in 34 provincial-level administrative regions in China and over 30 countries worldwide [5] - WORK Medical has received quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration, allowing entry into the U.S. market [5]
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance